Anaesthesia & Respiratory Devices Market Report

Global Anaesthesia & Respiratory Devices Market Size

The global anaesthesia and respiratory devices market size was valued at USD 33.18 billion in 2025 and is anticipated to reach USD 36.13 billion in 2026 from USD 71.41 billion by 2034, growing at a CAGR of 8.89% during the forecast period from 2026 to 2034.

Anesthesia and Respiratory Devices detect and cure respiratory diseases such as chronic obstructive pulmonary disease, asthma, tuberculosis, and pneumonia. These devices provide improved care for patients with acute and chronic respiratory illnesses. Over the last decade, the increased prevalence of the respiratory disease has been a critical driver of such a market. During surgery, anesthesia devices control pain, breathing, blood pressure, blood flow, heart rate, and rhythm. The patient's condition caused by anesthesia results in loss of sensation or consciousness. This may include analgesia (pain relief or prevention), paralysis (muscle relaxation), amnesia (memory loss), or loss of consciousness.

MARKET DRIVERS

Rapid urbanization, an increase in the number of surgeries, an increase in environmental pollution, an increase in the elderly population, and an increase in tobacco consumption are driving the global anesthesia and respiratory devices market. In addition, factors such as ventilator-related innovations and government support for the adoption and approval of these devices continue to drive the growth of the global anesthesia and respiratory devices market. In addition, the high demand for therapeutic home medical devices and rising medical costs are expected to provide a favorable growth opportunity for the market. According to the report released by World Health Organization (WHO), in 2018, about 235 million people had asthma, a critical non-communicable disease.

In addition, the anesthesia machine is primarily used in all types of surgery because it is designed to supply the mixed medical gas accurately and continuously while supplying the patient with anesthetic vapor at a safe pressure and flow rate. Therefore, more and more surgeries are expected to drive the growth of the anesthesia and ventilation market.

The rise in the number of people who smoke tobacco will upsurge anesthesia and respiratory devices marketplace in the forecast timeframe.Smoking causes lung cancer and is the reason for approximately 90% of deaths; hence people who smoke cigarettes regularly are much more likely to die from COPD than people who don't smoke. Also, according to the report released by the Centers for Disease Control and Prevention (C.D.C.), approximately forty million adults in the U.S.A and around 4.7 million middle and early childhood age people smoke a minimum of one tobacco product each day including e-cigarettes. Each year, the U.S. spends almost USD 70 billion on hospital therapy to deal with smoking-associated illnesses in adults. With such an escalating number of people who smoke and the developing occurrence of smoking-prompted breathing disorders, calls for anesthesia and breathing devices over the years.

In recent years, the market for anesthesia and respiratory devices has changed significantly due to the influence of COVID-19. Due to the pandemic, global G.D.P. shrank by about 3.5% in 2020. At the beginning of 2021, economic activity in many countries began to recover, partially adapting to pandemic restrictions. Vaccine research and development have made great strides, and many governments have taken various steps to stimulate economic recovery. Especially in the United States, it has the potential to provide a solid boost to economic activity, but the prospects for sustainable growth are increasing. Different sectors have been experiencing various benefits post-pandemic. The global economy is recovering from the Great Depression caused by COVID-19 but has long been below the pre-pandemic trend. The pandemic has exacerbated the risks associated with the decades-long wave of global debt accumulation. It could also amplify the long-awaited slowdown in potential growth over the next decade.

MARKET RESTRAINTS

Risks associated with diagnostic and therapeutic devices, particularly in infants, are limiting the growth of the anaesthesia and respiratory devices market. Furthermore, lack of awareness regarding the advanced therapeutic tools available in the market leads to the minimal adoption rate of the novel technologies, another major challenge for the key players operating in the global anaesthesia and respiratory devices market. Therefore, it is also likely to resist the market's growth during the forecast period.

Among the significant impediments to the growth of the global anesthesia and respiratory equipment market, the frequent one is product recalls initiated by the U.S. Food and Drug Administration (F.D.A.). Furthermore, high medical costs and non-reimbursement can also hamper the demand for anesthesia and ventilators. In addition, strict regulatory procedures can limit product approval, which can hinder the growth of the anesthesia and ventilation equipment market.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Device Insights

Based on device type, the respiratory devices segment contributes a significant share to the global anaesthesia and respiratory devices market, with the largest share in 2026. This segment is expected to grow further during the forecast period due to factors such as the rising prevalence of respiratory diseases due to the increasing population with smoking habits and failure of the respiratory system in the people exposed to severe air pollution. In addition, the influx of investments by public and private organizations in research activities for developing novel and innovative anaesthetic and respiratory devices and the increasing focus of various governments in developed and developing countries to provide enhanced healthcare to people also favor this sector development.

As of 2018, positive airway pressure devices dominate the complete anaesthesia and ventilator market, with the consistent prevalence of respiratory diseases such as cystic fibrosis, asthma, and tuberculosis experiencing significant growth during the forecast period. Machines include workstations, delivery machines, monitors, and ventilators. Anaesthesia disposables include masks and accessories. As the number of surgeries increases, anaesthetics increase, and the demand for anaesthesia machines is expected to increase.

REGIONAL ANALYSIS

Geographically, North America dominates the global anaesthesia and respiratory devices market in terms of revenue due to the healthy innovation, constant research and development, the sophisticated healthcare infrastructure, and favorable reimbursement policies of the government. The United States market adds a significant boost to the North American market and led this regional market in 2026. On the other end, the Canadian market is expected to grow moderately during the forecast period.

The U.S. market for anesthesia and ventilators is expected to experience favorable growth over the projected timeframe due to an increase in the incidence of respiratory disease coupled with an increase in the number of surgeries in the country. Furthermore, increasing patient propensity for home care with advanced products that offer portability, cost-effectiveness, and convenience will accelerate market growth. In addition, the presence of sophisticated healthcare systems and powerful ventilator distribution channels will drive the development of the U.S. anesthesia and ventilator industry.

The European market had a substantial share in the global market in 2026 and is predicted to register a healthy CAGR during the forecast period. High per capita income and growing investments in this region for the healthcare sector are expected to boost the European market. With increasing respiratory diseases such as asthma, lung cancer, tuberculosis, and chronic obstructive pulmonary disease (COPD), the German market for anesthesia and ventilation equipment is expected to multiply in the predicted year. High demand is due to advanced technology devices that provide portability and connectivity features that drive product demand. Therefore, the growing demand for highly innovative technologies and devices, coupled with the increasing baby boom generation, will drive the growth of the German anesthesia and ventilation equipment business.

The Asia Pacific is expected to have the highest growth rate during the forecast period. Factors such as the growing prevalence of tuberculosis and asthma in this region are significant factors adding to growth. Additionally, growing pollution levels in highly populated countries such as China, India, and Japan are further estimated to drive the Asia Pacific market. Furthermore, the Asia Pacific region is also expected to grow in the global anesthesia, and respiratory equipment market as manufacturers adopt inorganic strategies such as collaborations, acquisitions, and partnerships to expand their portfolio and market presence in China. Japan has accounted for a significant market share in the Asia Pacific region. The substantial increase in Japan's elderly population is driving the market growth. Asia-Pacific countries like India and China are also expected to witness a considerable population suffering from lung disease. As per the World Health Organization (WHO) report, about 90% of COPD-related deaths occur in low and middle-income countries.

KEY MARKET PLAYERS

Some of the promising companies that are playing a dominating role in the global anaesthesia and respiratory devices market include

• Medtronic
• Draegerwerk AG
• Philips Respironics
• ResMed Inc.
• OSI Systems
• Mindray
• GE Healthcare
• Masimo
• Getinge Group
• Fisher & Paykel
• Covidien
• AirSep Corp.
• ALung Technologies Inc.
• BomiMed Inc.
• 3M
• CareFusion Inc.
• AstraZeneca
• Invacare
• Teleflex Inc.
• Smiths Medical

MARKET SEGMENTATION

This research report segmented and sub-segmented the global anaesthesia and respiratory devices market based on device and region.

By Device

• Anaesthesia Devices          
  • Anaesthesia Machines
  • Anaesthetic Monitors
  • Anaesthetic Vaporizers
  • Analgesic Machines
  • Anaesthetic Masks
  • Anaesthetic Accessories
• Respiratory Devices           
  • Humidifiers
  • Resuscitators
  • Breathing Circuits
  • Chambers
  • CPAP Devices
  • Masks
  • Oxygen Concentrators
  • Nebulizers
  • Ventilators
  • Inhalers
  • Tracheotomy Tubes
  • Oxygen Cannula
  • Capnography
  • Spirometers

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa